Shanghai Haixin Group Co., Ltd. (SHA:600851)

Market Cap	6.56B +4.5%
Revenue (ttm)	705.50M -10.6%
Net Income	171.91M +13.3%
EPS	0.14 +13.3%
Shares Out	1.21B
PE Ratio	54.71
Forward PE	n/a
Dividend	0.05 (0.64%)
Ex-Dividend Date	Jul 24, 2026

Volume	6,228,677
Open	7.84
Previous Close	7.87
Day's Range	7.70 - 7.86
52-Week Range	6.40 - 10.69
Beta	0.59
Analysts	n/a
Price Target	n/a
Earnings Date	Aug 21, 2026

About Shanghai Haixin Group

Shanghai Haixin Group Co., Ltd. engages in the manufacture and sale of pharmaceutical products in China and internationally. It is also involved in leasing of industrial park properties, financial investment and commodity trading, as well as production and sales of chemical drugs through its sales platform or local distributors; and research and development, production, and sales of plush fabrics and clothing. The company also offers property and value-added services. Shanghai Haixin Group Co., Ltd. was founded in 1986 and is headquartered in S...

• Industry: Conglomerates
• Sector: Industrials
• Founded: 1986
• Employees: 675
• Stock Exchange: Shanghai Stock Exchange
• Ticker Symbol: 600851

Financial Performance

In 2025, Shanghai Haixin Group's revenue was 757.52 million, a decrease of -4.82% compared to the previous year's 795.88 million. Earnings were 176.00 million, an increase of 16.60%.

Data Sources: S&P Global Market Intelligence and Financial Modeling Prep

Fundamental and historical data is provided by S&P Global Market Intelligence. Delayed stock pricing data is provided by Financial Modeling Prep.

Last checked:

Aug 3, 2026

Data Sources Report a data error